Open Label Extension of LipoLat-CS202

Peregrine Ophthalmic

Status: Completed

Conditions: Glaucoma

Treatments: Other: Observation only

Study type: Observational

Funder types: Industry

Identifiers

NCT02599688

LipoLat-CS203

Details and patient eligibility

About

This is an open-label, observational extension of patients who received POLAT-001 in LipoLat-CS202.

Enrollment: 18 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Inclusion criteria

  1. Successful completion of 3 months of participation in Study LipoLat-CS202.
  2. Treatment with POLAT-001 in Study LipoLat-CS202.
  3. Able and willing to give signed informed consent and follow study instructions.

• Exclusion criteria

Excluded from the study will be individuals with the following characteristics:

1. The development, during study LipoLat-CS202, of any exclusion criteria from that study (e.g., concomitant medication or co-morbid disease).